Zimmer wins EU approval for $13.4 bln Biomet acquisition

BRUSSELS, March 30 (Reuters) - U.S. medical device maker Zimmer gained European Union regulatory approval on Monday for its proposed $13.4 billion purchase of rival Biomet after agreeing to divest three businesses in Europe to allay competition concerns.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.